Clinical Trial

A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 13, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
A Phase I Study of the Safety and Tolerability of M1-c6v1 Administered Via Intravenously for Treatment of Patients With Locally Advanced or Metastatic Solid Tumors
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-09-19; most recent amendment 2025-03-10.
Status change: Not Yet Recruiting → Recruiting 2024-05-13
Trial Details
NCT Number NCT06046742
Lead Sponsor Guangzhou Virotech Pharmaceutical Co., Ltd.
Conditions Solid Tumor
Enrollment 12 participants
Start Date 2024-07-10
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-20 (estimated)
Updated on ClinicalTrials.gov 2025-03-13